all

Join NLA faculty as they present “Myopathy and More: Getting Statins to Work in the Real World” at the AHA Scientific Sessions in Los Angeles on Monday, November 5 from 7:30 to 8:45 a.m.  Part of the session will focus on results from the USAGE survey, the largest known consumer survey on statin adherence, which was conducted by the NLA in partnership with Kowa Pharmaceuticals and Eli Lilly & Co. NLA faculty for this AHA session include Jerome Cohen, MD; Matthew Ito, PharmD; and Paul Thompson, MD.

In connection with the Familial Hypercholesterolemia ("FH") initiative of the Foundation of the National Lipid Association, the NLA held a consensus conference in January 2011 to bring together experts on FH for the generation of an NLA statement of clinical guidance regarding the diagnosis and treatment FH. Click here to view the manuscript, published in the May 2011 edition of the Journal of Clinical Lipidology.

SCOTTSDALE, Ariz.—The National Lipid Association (NLA), a nonprofit, multidisciplinary medical society focused on enhancing the practice of lipid management in clinical medicine, marks a major milestone this year with its tenth anniversary. Lipid management involves the treatment of disruptions in the amount of lipids in the blood (dyslipidemia). Lipids are fats and normal levels are required for good health. However, abnormally high or low lipid levels can lead to illness and cardiovascular disease, including arterial blockage, heart attack, and stroke.